Apple Inc.

Megacap tech-related stocks could end up being the story today as the broader market seems well supported but without a catalyst to make big moves higher.  The FAANG names—Facebook, Inc. (NASDAQ: FB), Apple Inc (NASDAQ: AAPL), Amazon.com, Inc. (NASDAQ: AMZN),...

The battle of the bands that’s played all year—growth vs. value—could keep blasting away in April as investors ponder rising Treasury yields, a reopening economy, and a Fed that’s staying on the sidelines. It’s a bit of a tug-of-war. So far, value is having more fun...

The market continues to relentlessly price in going back to normal at some point this year. Most forecasters on Wall Street are fixated on the short-term prospects of higher US economic growth following mass vaccination and the new $1.9 trillion recovery package. Wall Street also remains in wait-...

One of the market themes that’s been emerging as the vaccination rollout continues and economic optimism improves is that investors have been switching out of growth stocks and into names that stand to benefit as the economy recovers. While that’s beneficial for the likes of the ...

A year ago today marked the very bottom of the Covid selloff as the S&P 500 Index (SPX) plunged below 2200. That was down more than 35% from the all-time high just a month earlier, and things looked gloomy, to say the least.  If anyone then had told you then that in a year we...

If things get choppy today, you can probably blame the Fed.  Their meeting gets underway soon and we could have a bit of turbulence between now and tomorrow afternoon when Fed Chairman Jerome Powell addresses the media. Everyone is waiting pretty much on the edge of their seats to hear what,...

A year ago today, the pandemic slammed home for millions of Americans as the professional basketball season got suspended with some games halfway through and others about to tip off.  Covid ended up being sort of the ultimate Black Swan, or exceptional event, for the markets. It was something...

Friday’s momentum melted away like snow in the March sun. Then it appeared to come back, at least for parts of Wall Street. The Nasdaq (COMP) isn’t one of them. Things didn’t start out all over the place like they are now. Major indices initially rose in sync during the...

The “tug of war” between investors and the Fed continues, with the Tech sector taking the brunt of the blow. Major indices are in the red again this morning with the Nasdaq (COMP) on pace to post its third-straight losing week for the first time in about six months. Rising...

Looking for direction this week? Consider buying an atlas, because the market isn’t providing much. Up big on Monday, down sharply yesterday, and mixed today. It’s a choppy pattern, and we’ll discuss lower down why this might be happening. Meanwhile, it’s a morning without...

After yesterday’s heart-wrenching finish, the question is whether things can recover a bit before the weekend. It looks like the bleeding has slowed, but a lot depends on what happens in the bond market.  All eyes remain on the 10-year Treasury yield, which rose as high as 1.6% yesterday...

Today’s a big day for Fed watchers. So is tomorrow. Meanwhile, the “Tech check” continues with selling overnight hitting mega-cap stocks in that sector.  We’ll talk more about Tech below. First, Fed Chairman Jerome Powell begins his semi-annual testimony to the Senate...

The market is putting its best foot forward to start the week, but that doesn’t mean caution has left the room. There’s a sense of continued progress on the COVID-19 front, with the vaccination pace gathering steam and many health experts expecting the rate to improve. When you add that...

The big story last week was a dramatic spike in volatility. Today, that appears to be unwinding quickly, perhaps lending some initial strength to the stock market. Futures on the major indices are advancing in the early going, and the Cboe Volatility Index (VIX) has moved back to the...

You could argue that the market spooked itself this week. Now it wasn’t as if there weren’t external reasons for the downturn. Between worries about slow vaccine rollout, weak European economic data, the appearance of the South African variant of the virus here, and a few disappointing...